SEC Filing Details
SEC Filing Details
Document Details
Form
Filing Date
May 12, 2020
Document Date
May 12, 2020
Form Description
Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3
Filing Group
Registration Statements
Company
Akebia Therapeutics
Issuer
Akebia Therapeutics, Inc.
Print Page
Email Page
Contact IR
Email Alerts
Tear Sheet
Akebia Therapeutics, Inc.
245 First Street, Suite 1400
Cambridge, MA 02142
+1 617.871.2098 phone
+1 617.871.2099 fax